Statistics from Altmetric.com
Dr S Czernichow, Unite de Recherche en Nutrition Humaine, Bobigny, France; email@example.com
How do weight-reducing agents affect glycaemic parameters and risk of type 2 diabetes in predisposed individuals?
Included studies were randomised, double-blind, placebo controlled trials (RCTs) that evaluated the effects of weight-reducing agents (eg, orlistat, sibutramine, and rimonabant) on fasting glucose or glycated haemoglobin (HbA1c) concentrations and had a duration of ⩾1 year. Studies of mixed populations were excluded. Outcomes included weight loss, fasting glucose and HbA1c concentrations, and diabetes.
Medline was searched from …
Source of funding: no external funding.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.